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DELTEX2 C-terminal domain recognizes and recruits 
ADP-ribosylated proteins for ubiquitination
Syed Feroj Ahmed1*, Lori Buetow1*, Mads Gabrielsen1, Sergio Lilla1, Chatrin Chatrin1,2,  
Gary J. Sibbet1, Sara Zanivan1,2, Danny T. Huang1,2†
Cross-talk between ubiquitination and ADP-ribosylation regulates spatiotemporal recruitment of key players in 
many signaling pathways. The DELTEX family ubiquitin ligases (DTX1 to DTX4 and DTX3L) are characterized by a 
RING domain followed by a C-terminal domain (DTC) of hitherto unknown function. Here, we use two label-free 
mass spectrometry techniques to investigate the interactome and ubiquitinated substrates of human DTX2 and 
identify a large proportion of proteins associated with the DNA damage repair pathway. We show that DTX2-catalyzed 
ubiquitination of these interacting proteins requires PARP1/2-mediated ADP-ribosylation and depends on the 
DTC domain. Using a combination of structural, biochemical, and cell-based techniques, we show that the DTX2 
DTC domain harbors an ADP-ribose–binding pocket and recruits poly-ADP-ribose (PAR)–modified proteins for 
ubiquitination. This PAR-binding property of DTC domain is conserved across the DELTEX family E3s. These findings 
uncover a new ADP-ribose–binding domain that facilitates PAR-dependent ubiquitination.
INTRODUCTION
Posttranslational modifications (PTMs) dynamically regulate pro-
tein function in all known cellular processes, including DNA damage 
repair (DDR), apoptosis, and proteasomal degradation. Ubiquitination 
is a PTM in which the small 8.6-kDa protein ubiquitin (Ub) is cova-
lently linked to a protein substrate to modulate protein localization 
and function (1). Substrate ubiquitination is performed by the con-
secutive action of three enzymes. Initially, Ub-activating enzyme 
(E1) uses Mg2+-ATP (adenosine triphosphate) to activate and transfer 
Ub to a Ub-conjugating enzyme (E2), forming an E2~Ub thioester 
in which the C-terminal Gly of Ub is conjugated to the active-site 
Cys of the E2. In the final step, a Ub ligase (E3) catalyzes transfer of 
Ub from E2~Ub to a lysine on substrate, forming an amide between 
the lysine N and the C-terminal Gly of Ub (2). The largest class of E3s, 
the RING E3s, is characterized by the presence of a RING domain 
that recruits E2~Ub and transfers Ub directly to substrate (3, 4).
In mammals, the DELTEX (DTX) family of RING E3s comprises 
five members (DTX1, DTX2, DTX3, DTX3L, and DTX4) (5, 6). 
Functionally, all members of the DTX family are mainly linked 
to developmental processes involving Notch signaling (5, 7–9). In 
addition, DTX3L has also been shown to play a role in modifying 
histones during DDR (6, 10, 11). Members of the DTX family are 
characterized by the presence of two homologous domains at their 
C termini, a RING domain for Ub transfer followed by a Deltex 
C-terminal (DTC) domain for which the function remains unknown 
(12). The N termini of DTX family members diverge, but in DTX1, 
DTX2, and DTX4, this region comprises two consecutive WWE 
motifs (13). WWE motifs commonly function in binding poly– 
adenosine diphosphate (ADP)–ribosylated (PARylated) targets via 
their ability to recognize iso-ADP-ribose (iso-ADPr), the minimal 
subunit of PAR polymer containing the characteristic glycosidic 
linkage, and this has been validated for DTX1 (14–16). However, in 
the Drosophila melanogaster Dtx homolog, these two motifs 
comprise a single domain that binds the intracellular domain of the 
Notch receptor to modulate Notch signaling (9, 13, 17).
PARylated proteins are abundant at DNA lesion sites where they 
are critical for regulating processes such as DDR and apoptosis 
(18, 19). In mammals, protein PARylation is performed by PAR 
polymerases (PARPs) (20). During DDR, upon detecting DNA 
lesions, PARP1 becomes active and promotes the formation of PAR 
chains on a number of targets including DTX2 (21, 22). Presumably, 
this functions as a signal to recruit DTX2 to DNA damage sites 
where it then ubiquitinates its targets. However, how DTX2 recruits 
substrate for ubiquitination is unknown. We suspected that the 
DTC domain might have a role in substrate ubiquitination based on 
sequence contiguity with the RING domain, so we determined the 
structure of a C-terminal fragment of human DTX2 comprising 
these two domains. We subsequently identified putative DTX2 sub-
strates using two different label-free quantitative mass spectrometry 
(MS) methods and validated two of the identified targets in cell-based 
assays. Using a combination of structural studies, cell and biochem-
ical assays, we show that DTX2-mediated ubiquitination depends 
on the ability to bind PARylated substrate via the DTC domain.
RESULTS
DTX2 RING-DTC structure
To investigate a possible role for the DTC domain of the DTX 
family of E3 ligases in ubiquitination, we determined structures of a 
C-terminal fragment of human DTX2 encompassing the RING and 
DTC domains (residues 390–C; hereby referred to as 2RD) (Fig. 1, A 
and B, and Table 1). Crystals were obtained in two conditions and 
have either one or two molecules per asymmetric unit. On the basis 
of these structures, 2RD is a monomer. The RING and DTC domains 
of 2RD resemble the previously determined nuclear magnetic reso-
nance structure of mouse DTX2 RING domain and crystal struc-
ture of the DTC domain from human DTX3L. Superposition of the 
RING (residues 390 to 479 in 2RD) or the DTC (residues 480–C in 
2RD) domains yields a root mean square deviation (RMSD) ranging 
from 0.68 to 0.74 Å across 74 to 81 C atoms or an RMSD ranging 
from 0.50 to 0.67 Å across 97 to 106 C atoms. The orientation 
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between the RING and DTC domains differs across the three mole-
cules in the 2RD crystal structures, suggesting that there is a degree 
of rotational flexibility between the two domains (Fig. 1C). The 
three molecules of 2RD superpose with an RMSD ranging from 0.98 
to 2.69 Å across 195 to 213 C atoms, whereas the RING domains 
superpose with an RMSD ranging from 0.36 to 0.47 Å and the DTC 
domains superpose with an RMSD ranging from 0.30 to 0.31 Å 
across 72 to 80 and 120 to 125 C atoms, respectively.
The proximity of the RING and DTC domains and the rotation-
al flexibility between them suggest that the DTC domain may have 
a role in substrate ubiquitination. To further explore this possibility, 
we built a model of 2RD bound to UbcH5B~Ub by superposing the 
A
WWEWWE RING DTC
B C
D E
F
2RD
Fig. 1. Structure of 2RD. (A) Domain architecture of DTX2. (B) Cartoon representation of 2RD from crystal condition 1. The RING and DTC domains are colored cyan and 
green, respectively. Zn2+ ions are shown as gray spheres. (C) C ribbon overlay of the three molecules of forms 1 and 2 of 2RD. The DTC domains have been superposed 
to illustrate the flexibility between the RING and DTC domains. The molecule from condition 1 is colored green, and the two molecules from condition 2 are colored cyan 
and blue. (D) Model of 2RD bound to UbcH5B~Ub. The RING domain of 2RD was superposed with the RNF38 RING domain from the RNF38-UbcH5B~Ub complex (PDB 
4V3L) to generate the model. Surface representation of 2RD colored green and oriented as in (A); cartoon representation of UbcH5B~Ub with UbcH5B and Ub colored 
gray and wheat, respectively. The red arrow indicates the position of the UbcH5B~Ub thioester. (E) Model of 2RD bound to UbcH5B~Ub. As in (D) but with surface repre-
sentation of 2RD colored by charge potential. The circled area contains the charged pocket proximal to the UbcH5B~Ub thioester (indicated by the red arrow). (F) Sequence 
alignment of the RING-DTC fragment from the DTX family of E3s. Residues comprising the charged pocket proximal to the modeled UbcH5B~Ub thioester are highlight-
ed in red, and conserved residues defined by an ALSCRIPT (56) level of 0.7 are highlighted in black.
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RING domain of 2RD onto the RING domain of the E3 RNF38 
bound to UbcH5B~Ub [Protein Data Bank (PDB) 4V3L] (Fig. 1D). 
In the model, UbcH5B~Ub abuts the DTC domain and the thioester 
is oriented toward a charged pocket on the DTC domain (Fig. 1E). 
This pocket comprises residues that are highly conserved in sequence 
alignment of the RING-DTC domains of DTX family members 
(Fig. 1F) and in structural alignment with the DTX3L DTC domain. 
On the basis of the apparent proximity of the thioester to this con-
served pocket and the flexibility between the RING and DTC do-
mains, we thought that the DTC domain might bind substrate during 
DTX2-mediated ubiquitination (Fig. 1D). Furthermore, because 
this pocket is conserved in all DTX family members, it suggests that 
DTC interactors might share a common binding motif (Fig. 1, E and F).
DTX2 interacts primarily with DDR proteins
Little is known about the interactome of DTX2, so to identify 
potential binding partners of DTX2, we performed MS-based pro-
teomics on Myc-trap immunoprecipitations (IPs) from whole-cell 
lysates of human embryonic kidney (HEK) 293 cells transiently 
expressing Myc-tagged DTX2 (Myc-DTX2) or empty vector (EV). 
We identified 13 potential binding partners in total and found that 
10 of these are active in DDR (Fig. 2A and data S1). Among these, 
PARP1 was one of the highest scoring binding partners identified. 
We validated DTX2 interactions in coimmunoprecipitations with 
the following subset of binding partners identified in the pull-down: 
PARP1, FACT complex subunits SPT16 and SSRP1, x-ray repair 
cross-complementing proteins 5 and 6 (XRCC5 and XRCC6), and 
replication protein A 70-kDa DNA binding subunit (RPA1) (Fig. 2B).
To identify which of the DTX2-interacting substrates are ubiq-
uitinated by DTX2, we next performed Ub remnant profiling on 
whole-cell lysates from HEK293 cells overexpressing green fluores-
cent protein (GFP)–DTX2 or GFP. Because PARP1 and other DDR 
proteins were abundant in the pull-down, we thought that DTX2 
might have a role in DDR and performed the experiments following 
the induction of DNA damage with H2O2. Eight of the proteins 
identified in the Myc-trap pull-down were also present in the Ub 
remnant assay, including SPT16 and PARP1. In addition, 263 of the 
2087 peptides (corresponding to 71 of 1035 proteins) that were 
ubiquitinated in cells overexpressing GFP-DTX2 are involved in 
DDR (Fig. 2C and data S2). Despite their importance in DDR (23), 
no histones were identified with the Myc-trap pull-down and only 
one, namely, histone H3.1, was found in the Ub remnant assay. We 
confirmed the interaction of DTX2 with histone H3.1 by coimmuno-
precipitation (fig. S1) and then validated that both histone H3.1 and 
SPT16 were ubiquitinated in HEK293 cells by DTX2 (Fig. 2D).
Because PARP1 was identified in the DTX2 interactome and 
PARylation is a common posttranslational feature of many identi-
fied binding partners of DTX2 including SPT16 and histone H3.1 as 
well as DTX2 itself (21, 24), we next investigated the effects of ABT-888 
(veliparib), a PARP1 and PARP2 inhibitor, on substrate binding 
and ubiquitination. In the presence of ABT-888, none of the selected 
binding partners from the Myc-trap pull-down coimmunoprecipitated 
with DTX2 (Fig. 2B) nor did histone H3.1 (fig. S1). In addition, 
when cells were treated with ABT-888, ubiquitination of histone 
H3.1 and SPT16 in the presence of ectopically expressed DTX2 was 
reduced to a level similar to the control EV (Fig. 2D). Basal histone 
H3.1 and SPT16 mono-ubiquitination were observed in the control 
EV, likely because of other E3s or endogenous DTX2. In in vitro 
assays, glutathione S-transferase (GST)–2RD autoubiquitination was 
unaffected by ABT-888 (Fig. 2E), excluding the possibility that 
ABT-888 interferes directly with Ub transfer by the RING domain. 
Together, these data demonstrate that there is a link between ubiq-
uitination by DTX2 and PARylation by PARP1.
Ubiquitination of PARylated substrates requires  
DTC domain
WWE domains commonly bind PAR polymer (16), and in the 
RING E3 ligase RNF146, this domain links substrate PARylation 
and ubiquitination (16, 25–27); hence, there was a possibility that 
Table 1. Data collection and refinement statistics.  
DTX2 form 1 DTX2 form 2 DTX2-ADPr
PDB code 6Y22 6Y2X 6Y3J
Data collection
 Space group P3221 C2221 P3221
 Cell dimensions
  a, b, c (Å) 106.42, 106.42, 
74.67
41.76, 219.58, 
120.85
104.93, 104.93, 
74.54
  , ,  (°) 90.0, 90.0, 120.0 90.0, 90.0, 90.0 90.0, 90.0, 120.0
 Resolution (Å) 92.16–2.07 60.43–1.77 90.95–2.60
(2.12–2.07)* (1.82–1.77) (2.72–2.60)
 Rmerge 7.6 (74.8) 5.2 (77.0) 27.4 (161)
 Rpim 3.7 (36.0) 3.2 (47.4) 9.9 (59.7)
 I/I 16.5 (3.3) 14.4 (1.8) 5.3 (1.0)
 CC(1/2) 0.999 (0.973) 0.999 (0.581) 0.994 (0.822)
 Completeness 
(%)
99.7 (97.3) 100.0 (100.0) 100.0 (100.0)
 Redundancy 10.0 (10.0) 6.6 (6.8) 9.3 (8.9)
Refinement
 Resolution (Å) 29.01–2.07 
(2.12–2.07)
60.43–1.77 
(1.82–1.77)
45.48–2.6 
(2.72–2.60)
 No. of reflections 29,929 54,018 28,029
 Rwork/Rfree (%) 18.02/20.92 24.2/27.4 23.76/28.22
 No. of atoms
  Protein 1,742 2,998 1,745
  Ions 2 4 2
  Ligand 36
  Water 92 258 20
 B-factors (Å2)
  Protein 56.3 56.44 58.35
  Ions 48.17 73.50 61.96
  Ligand 56.71
  Water 55.15 51.78 49.41
 RMSD
  Bond 
lengths (Å)
0.006 0.006 0.011
  Bond angles (°) 0.829 0.841 1.331
*Values in parentheses are for highest-resolution shell.
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Fig. 2. Identification of DTX2 substrates. (A) Volcano plot displaying proteins that bind to Myc-DTX2 versus EV. Myc-trap pull-downs were performed in triplicate on 
whole-cell lysates from HEK293 cells expressing Myc-DTX2 or EV. Proteins shown as blue dots were identified as significantly enriched proteins using a t test with a 5% 
false discovery rate (FDR) in all three replicates and more abundant in Myc-DTX2 pull-downs compared to EV. Associated with data S1. (B) Immunoblots of Myc-trap pull-
downs of whole-cell lysates from HEK293 cells expressing Myc-DTX2 or EV in the presence and absence of ABT-888 using anti-PARP1, anti-SPT16, anti-SSRP1, anti-XRCC5, 
anti-XRCC6, anti-RPA1, anti–Myc-tag, or anti-actin as indicated. (C) Volcano plot displaying log2 fold change in intensities in peptides modified with Ub from lysates from 
HEK293 cells expressing GFP-DTX2 compared to EV. Assays were performed in triplicate, and significant changes in ubiquitinated peptide intensities were determined 
using a Student’s t test with a 1% FDR (permutation-based). Significantly changed ubiquitinated peptides present in all three replicates, more abundant in lysates from 
cells expressing GFP-DTX2, and from proteins annotated in the Gene Ontology database with the term “DNA repair” are colored as indicated. Associated with data S2. 
(D) Immunoblots of SPT16 (left) and histone H3.1 (right) ubiquitination by DTX2 in HEK293 cells expressing His-Ub, EV or Myc-DTX2, and GFP–histone H3.1 (right only) in 
the presence and absence of ABT-888. The cell lysates and Ni2+–pull-down products were immunoblotted with anti-GFP, anti-SPT16, anti–Myc-tag, or anti-actin antibodies 
as indicated. (E) Reduced in vitro autoubiquitination assay showing the formation of GST-2RD-IR-Ubn over time in the presence and absence of ABT-888. IR-Ub, Ub labeled 
with near-infrared dye. Visualized with the Odyssey CLx Imaging System (LI-COR Biosciences, top) and subsequently by staining with InstantBlue (Expedeon, bottom).
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the tandem WWE domains in DTX2 could play a similar role in 
binding PARylated substrate and facilitating ubiquitination. Given 
that the WWE domains of DTX2 are uncharacterized, we initially 
performed in vitro pull-down assays with a fragment comprising 
the N-terminal tandem WWE domains of DTX2 (DTX2-WWE) 
and found that this fragment bound PARylated PARP1 but not 
PARP1 (fig. S2, A and B). Furthermore, when tested in mammalian 
cell lysates, this fragment was sufficient to pull down histone H3.1 
and SPT16 (Fig. 3A) but not in the presence of ABT-888. Functional 
assays and sequence alignment with the WWE domain of RNF146 
have implicated Trp24 and Trp114 as critical PAR-binding residues 
in DTX2 (16), so we generated a W24A W114A double mutant 
(WDM) and tested its ability to bind PARylated substrates in mam-
malian cell lysates. DTX2-WWE WDM did not bind histone H3.1 
or SPT16 (Fig. 3A). Together, these data show that the tandem 
WWE domains of DTX2 bind PARylated substrate.
To explore the possibility that the tandem WWE domains in 
DTX2 serve as the functional link for binding PARylated substrate 
for ubiquitination, we performed cell-based ubiquitination assays 
on histone H3.1 and SPT16 using full-length DTX2 wild-type 
(DTX2 WT) and DTX2-W24A W114A (DTX2 WDM). Unexpectedly, 
both targets were ubiquitinated with similar efficiency (Fig. 3B) in 
the presence of DTX2 WT or DTX2 WDM, suggesting that the 
WWE domains have a limited or nonessential role in DTX2-mediated 
substrate ubiquitination. Involvement of the tandem WWE domains 
in substrate ubiquitination by DTX2 cannot be excluded given their 
PAR-binding potency. However, on the basis of the lack of sequence 
contiguity of the WWE and RING domains, we speculated that the 
contribution of the tandem WWE domains on DTX2 substrate 
ubiquitination might not be direct. Hence, we investigated the DTC 
domain as a possible link between substrate PARylation and ubiq-
uitination based on our earlier structural analysis (Fig. 1). We tested 
the RING-DTC fragment of DTX2 in cell-based ubiquitination 
assays and found that it was sufficient to mediate ubiquitination of 
histone H3.1 and SPT16 (Fig. 3C); furthermore, ABT-888 reduced 
substrate ubiquitination by this DTX2 fragment to a level similar to 
that of the EV (Fig. 3C). From these data, we surmised that the DTC 
domain plays a role in linking PARP1-mediated PARylation and 
substrate ubiquitination.
Whether substrate ubiquitination depends on PARylation of 
DTX2 itself or a DTX2-binding partner is unclear. To investigate, 
we performed in vitro PARylation assays on histone H3.1 and 2RD 
with PARP1. Histone H3.1 was only PARylated in the absence of 
ABT-888, whereas 2RD was not PARylated in either condition 
(Fig. 3D). We then attempted to probe whether only PARylated his-
tone H3.1 was ubiquitinated by 2RD in vitro but could not because 
this form of the histone was insoluble. Instead, we produced a 
GFP-tagged histone H3.1 fragment (H3.1 tail-GFP; fig. S2C) that 
encompasses the identified ubiquitination site (data S2) and treated 
it with PARP1 and biotinylated nicotinamide adenine dinucleotide 
(NAD+) to generate PARylated H3.1 tail-GFP for in vitro ubiquiti-
nation assays with 2RD. PARylated H3.1 tail-GFP was ubiquitinated 
by 2RD but not unmodified H3.1 tail-GFP (Fig. 3E). To further verify 
the dependency on substrate PARylation for 2RD-mediated ubiq-
uitination, we also tested PARP from the bacterium Herpetosiphon 
aurantiacus (HaPARP) as a model substrate. His-tagged HaPARP 
was treated with biotinylated NAD+ to generate auto-PARylated 
HaPARP and pulled down with Ni2+-NTA (nitrilotriacetic acid) 
following ubiquitination with 2RD in the presence of E1, UbcH5B, 
and Ub. In the presence of 2RD, the apparent molecular weight of 
the bulk of the PARylated HaPARP shifted upward, consistent with 
ubiquitinated PARylated HaPARP. In addition, a higher molecular 
weight smear containing Ub and HaPARP was enhanced when 
HaPARP was PARylated (Fig. 3F). A basal smear of ubiquitinated 
products was observed in the control reaction lacking HaPARP, 
which was likely due to nonspecific binding to Ni2+-NTA (Fig. 3F). 
These results demonstrate that substrate PARylation is the mediating 
factor between these two PTMs. The proximity of the RING and 
DTC domains and PARylation-dependent ubiquitination require-
ments suggest that the DTX2 DTC domain plays a role in directly 
recruiting PARylated substrates.
ADPr binding site on DTX2 RING-DTC
To probe the mechanism of PAR binding by the DTC, we deter-
mined the structure of 2RD bound to ADPr to 2.60 Å (Fig. 4A and 
Table  1). The structure most closely resembles the apo-structure 
from condition 1, having an RMSD of 0.39 Å across 208 C atoms. 
ADPr binds within the pocket identified as a putative substrate- 
binding site in our model of apo-2RD bound to UbcH5B~Ub (Fig. 1) 
and makes numerous hydrophobic and electrostatic interactions 
with residues in the DTC domain (Fig. 4, B and C). Notably, most 
of the ADPr-interacting residues from the DTC are conserved 
across the DTX family (Fig. 1F): Trp578 and His594 form  bonds 
with the adenine ring of ADPr, and His582 forms a hydrogen bond 
with the C2′ hydroxyl of the ribose proximal to the adenine ring. 
The side chain of Arg535 and main chain of Ser567 and Ser568 form 
putative hydrogen bonds with oxygen atoms in the diphosphate 
motif of ADPr, and the side chains of Arg535 and Trp578 form weak 
electrostatic interactions with the ribose distal to the adenine ring.
To validate our complex structure and substrate ubiquitination 
model, we generated two mutants of DTX2 and assessed their ability 
to ubiquitinate our model substrate PARylated HaPARP in vitro 
and histone H3.1 and SPT16 in cells. RING domain residues Ile414 
and Tyr425 were substituted with Ala to abrogate E2~Ub binding in 
one mutant [referred to as RDM (RING double mutant)], and DTC 
domain residues Ser568, His582, and His594 were substituted with Ala 
to abolish ADPr binding in the second [referred to as DTM (DTC 
domain triple mutant)]. Surface plasmon resonance (SPR) binding 
assays confirmed that GST-2RD RDM did not bind UbcH5B S22R 
(a variant lacking the noncovalent “backside” Ub interaction) or UbcH5B 
S22R C85K–Ub (a stably conjugated variant of UbcH5B~Ub), 
whereas GST-2RD and GST-2RD DTM displayed similar binding 
affinities for UbcH5B S22R and UbcH5B S22R C85K–Ub (fig. S3 
and table S1). Correspondingly, in Ub transfer assays, the fraction 
of UbcH5B~Ub discharged to lysine by 2RD and 2RD DTM was 
comparable, whereas the fraction discharged by 2RD RDM was ap-
proximately the same as in the absence of E3 (Fig. 4, D and E). 
These data established that the RING domain of the DTC mutant, 
2RD DTM, binds UbcH5B~Ub and is catalytically competent. Next, 
we performed in vitro ubiquitination of PARylated HaPARP by 
monitoring shifts in the PARylated HaPARP bands as the readout 
of ubiquitination and observed that neither GST-2RD RDM nor 
DTM promoted ubiquitination of PARylated HaPARP (Fig. 4F). 
Likewise, in cells, ubiquitination of histone H3.1 or SPT16 by 
Myc-DTX2 RDM or DTM was similar to Myc-DTX2 WT treated 
with ABT-888 (Fig. 4G). These data are consistent with our pro-
posed model in which the DTC domain binds PARylated substrates 
to facilitate ubiquitination by the RING domain.
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PAR recognition by the DTC domain is conserved
Similarities in the DTC sequences of DTX family proteins suggest 
that all family members might share the ability to bind PARylated 
proteins via their DTC domains. This prompted us to investigate 
whether the DTC domain alone was able to bind PAR. Coimmuno-
precipitations of the DTC domains from the different DTX family 
members and PAR revealed that the DTC domains of all DTX 
family members bind PAR but not in the presence of ABT-888 
(Fig. 5A). These data demonstrate that the DTC domain alone from 
DTX family Ub ligases is sufficient to bind PARylated proteins.
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Because DTX1, DTX2, DTX3L, and DTX4 all have PAR-binding 
domains at their N and C termini, we reasoned that they might 
share PARylated substrate interactomes. Using MS-based proteom-
ics on Myc-trap IPs as described earlier, we generated an interaction 
network for these DTX proteins. Each DTX family E3 has a distinct 
protein interaction network, and only DTX2 shows a strong as-
sociation with DDR proteins (Fig. 5B and data S1). We wondered 
whether these differences could partly be attributed to their cellular 
localization and thus monitored the localization patterns of these 
four DTX family E3s using immunocytochemistry. DTX2 was 
localized mainly in the nucleus, whereas DTX1, DTX3L, and DTX4 
were mainly in the cytoplasm (Fig. 5C). These findings suggest that 
DTX family E3s recognize PARylated substrate through the DTC 
domain but have distinct interactomes and localization patterns.
DISCUSSION
Members of the DTX family of E3s are characterized by a conserved 
C terminus composed of a RING and DTC domain. Sequence 
contiguity of the RING and DTC domains in this family of E3s 
prompted us to postulate that the DTC domain contributes to 
substrate recognition and ubiquitination. On the basis of our struc-
tures of 2RD and sequence conservation with other DTX proteins, 
we anticipated that the DTC domain would bind protein substrates 
via a consensus peptide motif but were surprised to find that the 
common DTC-binding feature was PAR. Our data reveal that key 
residues of the ADPr binding site in the DTC domain are strictly con-
served in all members of the DTX family and that binding of 
PARylated targets by the DTC domain requires PARP1/2-mediated 
PARylation. These results define the DTC domain as a new ADP-ribose– 
binding module that facilitates PAR-dependent substrate ubiquiti-
nation in conjunction with the RING domain.
Although the structure of the DTC domain was initially deter-
mined in 2012 (12), this is the first instance in which an ADPr binding 
function has been demonstrated for this domain. In the 2RD-ADPr 
complex structure, ADPr binds within a DTC pocket that is con-
served across the DTX family, and in cells, the DTC domain is 
sufficient to pull down PARylated targets, regardless from which 
DTX protein it originates. Furthermore, when we perturb ADPr 
binding by introducing mutations into this DTC pocket, we abro-
gate ubiquitination of the model substrate PARylated HaPARP 
in vitro and reduce ubiquitination of histone H3.1 and SPT16 in 
cells. The C1″ and C2′ hydroxyl groups of the ribose rings distal and 
proximal to the adenine ring, respectively, which are required for 
PAR-chain assembly, are exposed in our 2RD-ADPr complex struc-
ture (fig. S4A), suggesting that the DTC domain could bind an 
ADPr subunit along a linear PAR chain. The C1″ hydroxyl of the 
ribose distal from the adenine ring also serves as the attachment site 
of PAR chains to substrate, and its accessibility raises the possibility 
that the DTC domain could bind to this ADPr subunit in PARylated 
substrate. Furthermore, the C2′ hydroxyl of the adenine ribose 
projects into an adjacent pocket (fig. S4A), hinting at the possibility 
that the DTC domain could prefer another PAR chain pattern. The 
preferences of the DTX2 DTC domain and whether this varies 
among DTX family members require further investigation.
Our data illustrate a structural connection in the cross-talk between 
ADP-ribosylation and ubiquitination, although this is not the first 
instance of such an example. The RING E3s RNF146 and CHFR 
respectively harbor a WWE domain and PBZ PAR-binding motif that 
contributes to the ubiquitination of PARylated substrates (18, 26, 27). 
In both E3s, the PAR-binding motifs are distal from the RING domains 
and function by recruiting PARylated substrates for ubiquitination 
by the RING domain. For RNF146, ubiquitination also depends 
on iso-ADPr binding to the WWE domain to induce a conforma-
tional change in the RING domain to facilitate E2~Ub binding (25). 
In DTX2, the DTC domain is linked to the RING domain, where 
ubiquitination is contingent on recruitment of ADP-ribosylated 
substrate by the DTC domain, presumably to bring substrate proximal 
to the E2~Ub binding site on the RING domain. The structural config-
uration of the RING-DTC motif suggests that efficient ubiquitination 
likely occurs when the DTC domain engages with an ADPr sub-
unit close to the substrate-PAR linkage site such that the RING 
domain–bound E2~Ub could reach substrate lysine sites. Thus, 
it seems likely that it might favor mono- or short poly-ADP-ribose 
modified substrates.
Four of the five DTX family members have a second method of 
binding PAR chains via tandem WWE domains or a binding 
partner. We confirmed that the tandem WWE domains from DTX2 
are competent in binding PARylated substrates. However, our 
mutagenesis analyses of the DTC and tandem WWE domains show 
that the DTC domain plays the prominent role in recruiting PARy-
lated substrates for ubiquitination. Our 2RD structures show that 
the RING domain is connected to the DTC domain by a five-residue 
linker. While this linker allows some degree of rotational flexibility 
between these two domains, the proximity of the RING and DTC 
domains could influence or limit substrate accessibility to RING 
domain–bound E2~Ub such that ubiquitination preferentially oc-
curs on PARylated substrates bound via the DTC domain. Given 
that the tandem WWE domains also bind PARylated substrates, 
what might be their role? A model of the tandem WWE domains 
from D. melanogaster Dtx protein bound to two molecules of 
iso-ADPr based on the structure of RNF146 WWE domain bound 
to iso-ADPr suggests that the two iso-ADPr binding sites in the Deltex 
tandem WWE domain are joined together (fig. S4B), thereby creat-
ing a larger pocket that could exhibit a preference for a yet uniden-
tified pattern of PAR. It is tempting to speculate that the tandem 
WWE domains might display high affinity for a particular PAR 
pattern that serves as the initial step of PARylated substrate recruit-
ment to cooperate with RING-DTC domain in ubiquitination. 
Further studies are required to determine how the tandem WWE 
and DTC domains coordinate to bind PARylated substrate for 
ubiquitination.
Given that PARylation and ubiquitination are critical for com-
municating signals between proteins to produce desired outcomes, 
this newly identified PAR-binding role of the DTC domain from 
the DTX family of E3 Ub ligases establishes another mechanism for 
cross-talk between these two modifications. Despite the similarities 
in the RING and DTC domains of DTX E3s, our data reveal that 
DTX2 predominantly associates with PARP1 and other PARylated 
DDR proteins. PARylation and Ub-mediated degradation of DNA 
damage proteins frequently occur as concerted events during DDR 
(18, 20) and whether DTX2 has a role in the DDR pathway merits 
further investigation. Because DTX family members have distinct 
interactomes, characterizing the role of PAR binding by the DTC 
domain will provide insights into their functions. Future studies are 
required to fully characterize the PARylation requirements for sub-
strate ubiquitination and the role of this PARylation-ubiquitination 
cross-talk in DTX-modulated pathways.
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MATERIALS AND METHODS
Mammalian cell lines
The mammalian cells used in this study are HEK293 and HeLa 
(cervical cancer). The HEK293 cells were grown in Dulbecco’s modi-
fied Eagle medium (DMEM), while the HeLa cells were grown in 
RPMI. The media were supplemented with 10% fetal bovine serum, 
streptomycin (0.1 mg/ml), penicillin (100 U/ml), and Gibco genta-
micin reagent (6 g/ml; ThermoFisher Scientific). DMEM and RPMI 
media were further supplemented with 20 mM l-glutamine. Cells 
were cultured in monolayer in 5% CO2 at 37°C. The cell lines were 
purchased from the American Type Culture Collection (ATCC) or 
German Collection of Microorganisms and Cell Cultures (DSMZ), 
revived, and sent for in-house cell line authentication by short tandem 
repeat profiling using GenePrint 10 System (Promega). The cell 
lines already in stock are authenticated every 2 years, and the cells in 
culture are also tested for mycoplasma through a rota-basis (~every 
6 months) in-house or earlier if required.
Construct generation
New constructs were generated using standard polymerase chain 
reaction–ligation techniques and verified by automated sequencing. 
GST-tagged constructs were cloned into pGEX4T-1 (GE Healthcare) 
modified with a Tobacco etch virus (TEV) cleavage site and an 
N-terminal uncleavable His-tag (pGEX4T1 HG TEV) or pGEX4T-3 
modified with a TEV cleavage site and a second ribosomal binding and 
multiple cloning site (pABLO TEV). Constructs with an N-terminal 
His-tag were cloned into pRSFDuet-1 (Novagen) modified with a 
TEV cleavage site following the N-terminal His-tag (pRSFDuet 
TEV) or into pRSFDuet TEV in which the N-terminal 6× His-tag has 
been replaced with a 12× His-tag (pRSFDuet 12× His TEV). DNA 
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Fig. 5. Characterization of DTX family E3s. (A) Immunoblots of Myc-trap pull-downs of whole-cell lysates from HEK293 cells expressing EV (−) or Myc-tagged DTC 
domains from DTX1, DTX2, DTX3L, or DTX4 in the presence and absence of ABT-888 using anti-PAR, anti–Myc-tag, or anti-actin as indicated. (B) Network of DTX protein 
interactors generated from MS analyses of Myc-trap pull-downs of individual DTX family members. Label-free quantification (LFQ) intensities using the Hawaii plot func-
tionality in Perseus were used to generate the networks. Associated with data S1. (C) Merged images from HeLa cells overexpressing GFP-DTX1, GFP-DTX2, mCherry-DTX2, 
GFP-DTX3L, or GFP-DTX4 as indicated. Cells on coverslips were fixed and mounted on glass slides using the nuclear stain DAPI (4′,6-diamidino-2-phenylindole). The scale 
bar (bottom right) represents 20 m in each panel.
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encoding the histone H3.1 tail (residues 1 to 43) was cloned into 
modified pRSFDuet-1 (Novagen), in which the N-terminal His-
tag was deleted and the Xho I site was followed by a TEV cleavage 
site and GFP–His-tag. DNA encoding PARP1 and its variant was 
cloned into pET-21a(+) (Novagen) in-frame with the uncleavable 
C-terminal His-tag. For His-Ub, DNA encoding MHHHHHH-Ub 
was cloned into pET-3a (Novagen); for IR-Ub, DNA encoding 
GGSC-Ub was cloned into pGEX4T1 HG TEV. Mammalian con-
structs were cloned into pcDNA3 modified with an N-terminal Myc-
tag (pcDNA3Myc), pGZdx21Z (28), pcDNA3.1 B(+), or mCher-
ry2-C1, a gift from M. Davidson (Addgene plasmid no. 54563).
Protein expression and purification
Escherichia coli BL21(DE3) GOLD cells were used for the expres-
sion of recombinant proteins. Cells were grown at 37°C in Luria- 
Bertani medium until reaching an OD600 (optical density at 600 nm) 
of 0.6 to 0.8. Expression was then induced with 0.2 mM isopropyl 
-d-1-thiogalactopyranoside at 18° to 20°C for 12 to 16 hours. Following 
expression, bacterial cells were harvested by centrifugation and 
lysed with a microfluidizer or sonicator. Cells expressing GST-tagged 
proteins were resuspended in 200 mM NaCl, 50 mM tris-HCl (pH 7.6), 
1 mM dithiothreitol (DTT), and 2.5 mM phenylmethylsulfonyl 
fluoride (PMSF), and cells expressing His-tagged proteins (including 
H3.1 tail-GFP) were resuspended in 200 mM NaCl, 25 mM tris-HCl 
(pH 7.6), 15 mM imidazole, 5 mM β-mercaptoethanol (BME), and 
2.5 mM PMSF, or, in the case of His-HaPARP variants, in 300 mM NaCl, 
25 mM tris-HCl (pH 8), 15 mM imidazole, 5 mM BME, and 2.5 mM 
PMSF. Cell lysates were cleared by high-speed centrifugation.
To purify DTX2, its variants, H3.1 tail-GFP and His-Ub, clari-
fied lysates were applied to glutathione affinity or Ni2+-agarose, 
depending on the tag system, using a gravity column or by incubating 
for 1 to 2 hours on a rotary shaker at 4°C. Resins were washed in 
buffers similar to the lysis buffer; GST-tagged proteins were eluted 
in 50 mM tris-HCl (pH 8.0), 200 mM NaCl, 1 mM DTT, 10 mM 
glutathione, and His-tagged proteins in 25 mM tris-HCl (pH 7.6), 
200 mM NaCl, 5 mM BME, and 200 mM imidazole. H3.1 tail-GFP 
was buffer-exchanged into 300 mM NaCl, 25 mM Hepes (pH 8), 
and 0.1 mM (tris(2-carboxyethyl)phosphine) (TCEP). All the other 
tagged proteins were further purified by size exclusion chromatography 
on a Superdex 75 or Superdex 200 column (GE Healthcare) equili-
brated in 150 mM NaCl, 25 mM tris-HCl (pH 7.6), and 1 mM DTT 
before snap-freezing in liquid nitrogen and storing at −80°C.
For removal of tags, protein samples were dialyzed against 25 mM 
tris-HCl (pH 7.6), 150 mM NaCl, and 5 mM BME overnight at 4°C 
in the presence of TEV protease. The proteins of interest were sepa-
rated from the affinity tags or the remaining uncleaved proteins by 
applying the dialyzed and cleaved samples onto the same resin and 
collecting the flow-through. Further purification was performed by 
size exclusion chromatography on a Superdex 75 column (GE 
Healthcare), pre-equilibrated in 25 mM tris-HCl (pH 7.6), 150 mM 
NaCl, and 1 mM DTT.
To purify His-HaPARP, clarified lysate was applied to a High 
Density Nickel Resin (Agarose Bead Technologies) gravity column; 
washed with 1 M NaCl, 25 mM tris-HCl (pH 8), 15 mM imidazole, and 
5 mM BME, followed by 300 mM NaCl, 25 mM tris-HCl (pH 8), 
15 mM imidazole, and 5 mM BME; and eluted with 300 mM NaCl, 
25 mM tris-HCl (pH 8), 300 mM imidazole, and 5 mM BME. His-HaPARP 
was dialyzed against 300 mM NaCl, 25 mM tris-HCl (pH 8), and 1 mM 
DTT before snap-freezing in liquid nitrogen and storing at −80°C.
To purify IR-Ub for labeling, clarified lysate from cells express-
ing HisGST-TEV-GGSC-Ub was applied onto a glutathione agarose 
resin column and washed in lysis buffer described above but with 
5 mM DTT. TEV protease and lysis buffer were added to the column, 
and GGSC-Ub was cleaved at 4°C overnight using a circular system 
and a peristaltic pump. The flow-through was collected and applied 
onto a Superdex 75 26/60 column (GE Healthcare) equilibrated in 
phosphate-buffered saline (PBS).
Other proteins were purified using previously described proto-
cols: Arabidopsis thaliana Uba1 (AtUba1) and UbcH5B S22R (29, 30), 
UbcH5B (30, 31), untagged Ub for Fig. 4E (30, 32), and stably con-
jugated UbcH5B C85K S22R–Ub (30, 33). PARP1-His was purified 
as described (34) but without gel filtration chromatography. Protein 
concentrations were determined either by measurement of the 
absorbance at 280 nm based on molar extinction coefficients cal-
culated from the relevant sequences using ExPASy’s ProtParam (35) 
or by Bradford assay using bovine serum albumin (BSA) as a standard.
SPR binding assays
The SPR experiments were performed with CM-5 chips (GE Healthcare) 
on a Biacore T200 at 25°C. GST and GST-tagged proteins were captured 
onto a CM-5 chip coupled with anti-GST to 1000 to 2000 response 
units. UbcH5B S22R C85K–Ub and UbcH5B S22R were serially diluted in 
running buffer [25 mM tris-HCl (pH 7.6), 150 mM NaCl, BSA (0.1 mg/ml), 
1 mM DTT, and 0.005% (v/v) Tween 20] to concentration ranges of 
0 to 100 M to measure binding. Differences in signal between 
GST-protein and GST alone are reported, and representative sensor-
grams were prepared in GraphPad Prism (version 8.1.0).
Crystallization
Purified His-2RD or 2RD was concentrated to ~10 mg/ml and 
screened in sitting drop vapor diffusion trays. Crystals of form 1 
(His-2RD) and form 2 (2RD) were obtained in 0.1 M tris-HCl (pH 7.6), 
36% glycerol ethoxylate, and Morpheus condition 60 (Molecular 
Dimensions), respectively. For the complex bound to ADPr, 2RD 
crystals similar to form 1 were obtained in Morpheus condition 39 
(Molecular Dimensions) and soaked in 10 mM ADPr for 30 s.
Data collection and structure determination
Data were collected at Diamond Light Source (DLS) beamlines I03 
and I04 and processed using the xia2 pipeline (36), including DIALS 
(37), POINTLESS (38), and AIMLESS (39). The structure of 2RD 
form 1 was determined using the fast_ep pipeline at DLS. The 
poly-Ala model was extended and corrected using COOT. The 
structures of 2RD form 2 and 2RD-ADPr complex were determined 
by molecular replacement using the structure of 2RD form 1 as the 
search model with PHASER (40). The structures were refined in 
BUSTER (41) or PHENIX (42) and manually inspected in COOT. 
TLS parameterization was used throughout. The final models were 
validated using MolProbity (43). All data processing and refinement 
statistics are presented in Table 1. Superimpositions and protein 
surface areas were respectively calculated in LSQMAN (44) and PISA 
(45), and figures were made in PyMOL (www.pymol.org). The Polder 
density map in Fig. 4C was calculated in PHENIX. Electrostatic surface 
potentials were calculated using PDB2PQR and APBS (46).
Interactome and Ub remnant sample preparations
For preparing samples for the determination of interactomes of dif-
ferent DELTEX proteins, EV and Myc-tagged full-length DTX1, 
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DTX2, DTX3L, and DTX4 were expressed in HEK293 cells and 
pulled down with Myc-trap (Chromotek) in triplicate experiments. 
The beads were washed twice with IP lysis buffer and once each 
with IP wash buffer and high-performance liquid chromatography–
grade water, and processed following a previously established pro-
tocol (47). Digestion of samples was performed by subsequent use 
of both endoLysC and trypsin in AMBIC. For preparing samples 
for Ub remnant motif analysis of DTX2-ubiquitinated substrate 
peptides using PTMScan Ubiquitin Remnant Motif (K--GG) Kit 
(Cell Signaling Technology, catalog no. 5562), EV and GFP-DTX2 
were overexpressed in HEK293 cells in triplicate plates, induced 
with 50 M H2O2 (Sigma-Aldrich) for 10 min, and further treated 
with MG132 (Sigma-Aldrich) for 4 hours. Lysates were prepared 
and processed following the manufacturer’s protocol.
MS data collection and processing
Peptides resulting from all trypsin digestions were separated by 
nanoscale C18 reverse-phase liquid chromatography using EASY-nLC 
II 1200 (ThermoFisher Scientific) coupled to an Orbitrap Fusion 
Lumos mass spectrometer (ThermoFisher Scientific). Elution was 
carried out at a flow rate of 300 nl/min using a binary gradient, into 
a 50-cm fused silica emitter (New Objective) packed in-house with 
ReproSil-Pur C18-AQ, 1.9-m resin (Dr. Maisch GmbH), for a total 
run time duration of 135 min. The packed emitter was kept at 50°C 
by means of a column oven (Sonation) integrated into the Thermo 
Scientific Nanospray Flex ion source from which eluting peptides 
were electrosprayed into the mass spectrometer. An Active Back-
ground Ion Reduction Device (ESI Source Solutions) was used to 
decrease air contaminant signals. Xcalibur software (ThermoFisher 
Scientific) was used for data acquisition. A full scan over a mass range 
of 350 to 1400 mass/charge ratio (m/z) was acquired at 120,000 resolu-
tion at 200 m/z. Higher-energy collisional dissociation fragmentation 
was performed on the 15 most intense ions, and peptide fragments 
generated were analyzed in the Orbitrap at 15,000 resolution.
The MS raw data were processed with MaxQuant software version 
1.6.3.3 (48), and peptides were identified with the Andromeda search 
engine (49), querying Swiss-Prot (50) Homo sapiens (30/04/2019; 
42411 entries). First and main searches were performed with precur-
sor mass tolerances of 20 and 4.5 parts per million (ppm), respec-
tively, and an MS/MS tolerance of 20 ppm. The minimum peptide 
length was set to six amino acids, and specificity for trypsin cleavage 
was required. Methionine oxidation and N-terminal acetylation 
were specified as variable modifications, whereas cysteine carbami-
domethylation was set as a fixed modification. For the Ub remnant 
experiment, GlyGly-Lys was included as a variable modification. 
The peptide, protein, and site false discovery rate (FDR) was set to 
1%. All MaxQuant outputs were analyzed with Perseus software 
version 1.6.2.3 (51).
Transfections, coimmunoprecipitation, and  
Western blotting
Lipofectamine 2000 (ThermoFisher Scientific) or Polyplus (Polyplus- 
transfection) reagents were used to transfect the cell lines with the 
plasmids following the manufacturers’ protocols. Unless otherwise 
mentioned, cells were harvested 48 hours after transfection. Cells 
were resuspended in IP lysis buffer [50 mM tris-HCl (pH 7.5), 150 mM 
NaCl, 1 mM EDTA, 1% IGEPAL CA-630, 10% glycerol, 0.5 mM 
DTT, and protease inhibitor cocktail] to prepare whole-cell lysates 
for Western blot and IP as described previously (52). For IP using 
Myc-trap (Chromotek), the lysates were incubated for 1 hour with 
the respective traps. The beads were washed twice with IP lysis buf-
fer and once with IP wash buffer (IP lysis buffer consisting of 200 mM 
NaCl and 1.0 mM DTT). In addition, all lysis and incubation buf-
fers for IPs and pull-downs contained 2 M ABT-888 (Santa Cruz 
Biotechnology) to inhibit PARylation of substrates during lysis. 
Immunoprecipitated proteins were eluted in 40 l of 2× loading dye at 
95°C. Immunoblotting was performed as described previously 
(52) with some modifications. Protein samples were separated by 
SDS–polyacrylamide gel electrophoresis (SDS-PAGE) in NuPAGE 
4 to 12% bis-tris precast gels using either MES SDS or Mops SDS 
running buffer. The samples were then transferred onto nitrocellulose 
membranes from Trans-Blot Turbo Transfer Packs using a Trans-
Blot Turbo transfer system. The immunoblots were scanned on the 
Odyssey CLx Imaging System (LI-COR Biosciences). Actin was 
used as a loading control in the immunoblots from cell-based assays. 
For Fig. 2B, multiple gels were run under similar conditions to 
probe all the target proteins through immunoblotting and actin 
presented is representative of all the actins probed for each separate 
gel. The following dilutions of primary antibodies have been used in 
immunoblotting: rabbit anti-PARP1 (1:1000; Cell Signaling Technology, 
catalog no. 9532), rabbit anti-SPT16 (1:1000; Cell Signaling Tech-
nology, catalog no. 12191), rabbit anti-SSRP1 (1:1000; Cell Signaling 
Technology, catalog no. 13421), rabbit anti-XRCC5 (1:1000; Cell 
Signaling Technology, catalog no. 2180), rabbit anti-XRCC6 (1:1000; 
Cell Signaling Technology, catalog no. 4104), rabbit anti-RPA1 
(1:1000; Cell Signaling Technology, catalog no. 2267), mouse anti-Myc 
tag (1:1000; Cell Signaling Technology, catalog no. 2276), goat anti-actin 
(1:1000; Santa Cruz Biotechnology, catalog no. sc-1616), mouse anti-GFP 
(1:1000; Santa Cruz Biotechnology, catalog no. sc-81045), mouse 
anti–histone H3.1 (1:1000; Cell Signaling Technology, catalog no. 14269), 
mouse anti–His-tag (1:1000; ThermoFisher Scientific, catalog no. 
MA1-21315), rabbit anti-PAR (1:500; Merck, catalog no. MABC547), 
mouse anti-GFP (1:1000; Cell Signaling Technology, catalog no. 2955), 
rabbit anti-Ub (1:1000; Sigma-Aldrich, catalog no. 662099), or mouse 
anti-Ub (1:1000; Cell Signaling Technology, catalog no. 3936). The 
secondary antibodies used are as follows: goat anti-mouse IRDye 
800CW (1:15,000; LI-COR Biosciences, catalog no. 925-32210), goat 
anti-rabbit IRDye 680LT (1:20,000; LI-COR Biosciences, catalog no. 
925-68021), goat anti-mouse IRDye 680LT (1:20,000; LI-COR 
Biosciences, catalog no. 925-68020), goat anti-rabbit IRDye 800CW 
(1:15,000; LI-COR Biosciences, catalog no. 026-32211), donkey anti- goat 
IRDye 800CW (1:15,000; LI-COR Biosciences, catalog no. 925-32214), 
or NeutrAvidin Protein, DyLight 800 (1:15,000; ThermoFisher 
Scientific, catalog no. 22832).
Labeling IR-Ub
GGSC-Ub was incubated with a 1.2-fold molar excess of IRDye 
800CW Maleimide (LI-COR Biosciences) for 2.5 hours at room 
temperature in the dark and subsequently buffer-exchanged into 
150 mM NaCl and 25 mM tris-HCl (pH 7.6) by passing the mixture 
consecutively over two Zeba Spin Desalting columns (ThermoFisher 
Scientific). The concentration of labeled Ub was estimated on the 
basis of a 95% recovery rate per desalting column. A 20:1 molar ratio 
of unlabeled-to-labeled GGSC-Ub was used for assays.
In vitro ADP-ribosylation and ubiquitination assays
For Fig. 2E, A. thaliana Ub-activating enzyme E1 (AtUba1; 1 M) 
was used to charge UbcH5B (10 M) with IR-Ub (100 M) for 2 min 
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at room temperature in 50 mM NaCl, 50 mM tris-HCl (pH 7.6), 5 mM 
MgCl2, and 5 mM ATP. GST-2RD (2.5 M) and ABT-888 [10 M; 
600 M stock in dimethyl sulfoxide (DMSO)] or DMSO (3.3%, v/v) 
were added, and aliquots were removed at indicated time points 
and quenched with 4× NuPAGE LDS Sample Buffer (Invitrogen). 
Samples were reduced with 125 mM DTT for 5 min at room tem-
perature before separating components with SDS-PAGE. Gels were 
visualized by staining with InstantBlue (Expedeon) after scanning 
with the Odyssey CLx Imaging System (LI-COR Biosciences).
For Fig. 3D, PARP1-His (1 M), duplex activating DNA (0.5 M), 
NAD+ (50 M), biotinylated NAD+ (12.5 M; Trevigen), ABT-888 
(10 M), histone H3.1 (0.75 M; New England Biolabs, M2503), 
and 2RD (0.75 M) were incubated at 23°C for 1 hour. Reactions 
were quenched with gel-loading dye. Samples were immunoblotted 
against NeutrAvidin Protein, DyLight 800 to identify biotinylated 
ADP-ribosylated products.
For Fig. 3E, H3.1 tail-GFP (20 M), PARP1 E988Q (1 M), duplex 
activating DNA (0.5 M), NAD+ (100 M), and biotinylated NAD+ 
(12.5 M; BIOLOG Life Science Institute) were incubated for 
1 hour at 30°C in 25 mM NaCl, 50 mM Hepes (pH 7.5), 5 mM MgCl2, 
and 1 mM TCEP and subsequently buffer-exchanged into 150 mM 
NaCl and 25 mM Hepes (pH 7.5) with Zeba Spin Desalting columns 
(ThermoFisher Scientific) to generate biotinylated ADP-ribosylated 
H3.1 tail-GFP. For unmodified H3.1 tail-GFP, NAD+ and biotinylated 
NAD+ were omitted. Ubiquitination reactions were performed for 
0.5 hour at 21°C with AtUba1 (0.4 M), UbcH5B (10 M), Ub (100 M), 
2RD (1 M), and H3.1 tail-GFP or biotinylated ADP-ribosylated 
H3.1 tail-GFP (9.6 M) in 50 mM NaCl, 50 mM tris-HCl (pH 7.6), 
5 mM MgCl2, and 5 mM ATP. Reactions were quenched with NuPAGE 
LDS Sample Buffer (Invitrogen) containing 250 mM DTT. Samples 
were immunoblotted against mouse anti-GFP and rabbit anti-Ub 
or mouse anti-Ub and NeutrAvidin Protein, DyLight 800.
For Figs.  3F and 4F, His-HaPARP (5 M), calf thymus DNA 
(0.05 mg/ml; Sigma-Aldrich), NAD+ (50 M), and biotinylated NAD+ 
(12.5 M; Trevigen) were incubated for 1 hour at 23°C in 25 mM 
NaCl, 50 mM Hepes (pH 7.5), 5 mM MgCl2, and 1 mM TCEP and 
subsequently buffer-exchanged into 150 mM NaCl, 25 mM tris-HCl 
(pH 7.6) or 150 mM NaCl, 25 mM Hepes (pH 7.5) with Zeba Spin 
Desalting columns (ThermoFisher Scientific) to generate biotinylated 
ADP-ribosylated His-HaPARP for ubiquitination assays. For His- 
HaPARP without ADP-ribosylation, either calf thymus DNA or calf 
thymus DNA and NAD+/biotinylated NAD+ were omitted.
For Fig. 3F, ubiquitination reactions were performed for 1 hour 
at 25°C in conditions identical to those described for Fig. 3E but 
with His-HaPARP or biotinylated ADP-ribosylated His-HaPARP 
(2.6 M). Reactions were subsequently incubated with Dynabeads 
His-tag matrix (Invitrogen) at 4°C for 30 min; washed with 0.3 M 
NaCl, 50 mM phosphate (pH 8), and 0.01% Tween-20; and eluted in 
wash buffer containing 300 mM imidazole. Samples were prepared 
with gel-loading dye containing 250 mM DTT and immunoblotted 
against NeutrAvidin Protein, DyLight 800 or mouse anti-His and 
rabbit anti-Ub.
For Fig. 4F, ubiquitination reactions were performed and quenched 
as described for Fig. 3E but with biotinylated ADP-ribosylated His-
HaPARP (2.1 M), BSA (0.2 mg/ml), and GST-2RD variants (0.9 M). 
Samples were immunoblotted against NeutrAvidin Protein, DyLight 800.
For the in vitro ADP-ribosylation and ubiquitination assays, 
samples were separated by SDS-PAGE in Mops running buffer, and 
gels and immunoblots were visualized by scanning with the Odyssey 
CLx Imaging System (LI-COR Biosciences). Final concentrations 
are in parentheses.
In vitro single-turnover lysine discharge assays
AtUba1 (0.4 M) was used to charge UbcH5B (20 M) with IR-Ub 
(30 M) for 15 min at 23°C in 50 mM tris-HCl (pH 7.6), 50 mM 
NaCl, 5 mM MgCl2, and 5 mM ATP. Charging was stopped by 
incubating the reaction with 50 mM EDTA for 1 to 2 min. Discharge 
was initiated by the addition of a mixture containing l-lysine (130 mM) 
and GST-2RD variant (1.1 M). Reactions were quenched at indi-
cated times with 4× loading dye and resolved by SDS-PAGE. Gels 
were visualized using the Odyssey CLx Imaging System (LI-COR 
Biosciences). Final concentrations are in parentheses except for 
UbcH5B and IR-Ub, which were 7.5 and 11.25 M, respectively.
In vitro pull-down of PARylated PARP1-His
PARP1-His (2.1 M) was incubated with duplex activating DNA 
(0.5 M) and NAD+ (100 M) for 1 hour at 30°C. For unPARylated 
samples, NAD+ was omitted. Reactions were buffer-exchanged into 
wash buffer [0.2 M NaCl, 50 mM tris-HCl (pH 7.6), 1 mM DTT, 
1 mM EDTA, and 0.5% IGEPAL CA-630] with Zeba Spin Desalting 
columns (ThermoFisher Scientific). Equimolar amounts of GST or 
GST-DTX2 WWE were incubated with Glutathione Agarose-4B 
Resin (Agarose Bead Technologies) and 15 g of PAR-PARP1-His 
or PARP1-His, washed in wash buffer, and eluted with 1× gel-loading 
dye containing 50 mM DTT. Samples were separated by SDS-PAGE 
in Mops running buffer and visualized by staining with InstantBlue 
(Expedeon) or immunoblotting against anti-PAR (1:1000) and 
anti-PARP1 and scanning with the Odyssey CLx Imaging System 
(LI-COR Biosciences).
Cell-based ubiquitination assays
The ubiquitination assays from mammalian whole-cell lysates were 
performed under denaturing condition. HEK293 cells were trans-
fected with His-Ub and other plasmids to overexpress the proteins 
as indicated in the figures. Twenty-four hours after transfection, the 
cells were treated with 50 M ABT-888 as indicated in the figures. 
The cells were harvested after 36 hours following treatment with 
50 M MG132 for 4 hours. In Figs. 3B and 4G, the cells were treated 
with 50 M H2O2 for 30 min before MG132 treatment. Five percent 
of the cells were kept as separate pellets; the remaining were sus-
pended in 750 l of lysis buffer UBA [8 M urea, 0.3 M NaCl, 50 mM 
phosphate (pH 8.0), and N-ethylmaleimide (NEM; 100 g/ml)] and 
sonicated. Lysate concentrations were estimated using a NanoDrop 
spectrophotometer (Denovix), and each lysate was normalized to a 
volume of 1 ml to have equal concentrations. Dynabeads His-tag 
matrix (Invitrogen) was added to the lysates and incubated on a 
rotatory shaker at 4°C overnight. The beads were washed with UBA, 
UBB, UBC, and PBS [UBB = UBA and UBC 1:1; UBC = 0.3 M NaCl, 
50 mM phosphate (pH 8.0), NEM (100 g/ml)] and eluted in 2× 
protein loading dye by incubating at 95°C for 10 min. Lysates from 
the saved pellet was prepared in IP lysis buffer. The eluted samples 
and whole-cell lysates were resolved using SDS-PAGE and immu-
noblotted with the antibodies as indicated in the figures.
Immunocytochemistry
The cells (overexpressing GFP or mCherry-tagged proteins) on covers-
lips were washed thrice with PBS and fixed in methanol. The coverslips 
were then mounted onto glass slides containing VECTASHIELD 
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antifade mounting medium (Vector Laboratories) and sealed. The 
images were captured on a Zeiss 710 upright confocal microscope at 
×60 (oil) magnification.
Quantification and statistical analysis
For the affinity purification MS experiment, protein abundance was 
measured using the label-free quantification (LFQ) algorithm available 
in MaxQuant (53) and is reported in data S1. Only proteins quanti-
fied in all three replicates in at least one group were kept for down-
stream analysis. Missing values were imputed separately for each 
column (width, 0.3; down shift, 1.8), and significantly enriched pro-
teins were selected using a t test with a 5% FDR (permutation-based) 
and reported in data S1. Only significantly enriched proteins in which 
log2 (Myc-DTX2/EV) > 0 were considered for further evaluation/
validation and colored in the volcano plot.
Networks of DTX protein interactors were generated from LFQ 
intensities using the Hawaii plot functionality in Perseus (54). 
Different s0 and FDR% parameters were used in the multi-volcano 
analysis to define class A (higher confidence, s0 = 1, FDR = 0.01%) 
and class B (lower confidence, s0 = 1, FDR = 0.2%) potential inter-
actors. The generated data (data S1) were imported into Cytoscape 
3.7.2 (55) for network visualization.
The MaxQuant output GlyGly-Lys file (data S2) was used for 
quantification of ubiquitinated peptides. Reverse and potential 
contaminant flagged peptides were removed. Missing values were 
imputed separately for each column (width, 0.3; down shift, 1.8). 
Only ubiquitinated peptides that had a “score diff” greater than 5, 
had a localization probability higher than 0.75, and were robustly 
quantified in all three replicate experiments were included in the 
analysis. To determine significantly changing ubiquitinated peptides, 
a Student’s t test with a 1% FDR (permutation-based) was applied to 
the peptide intensities included in data S2. For the volcano analysis, 
s0 and FDR% were 0.5 and 1%, respectively. Ubiquitinated peptides 
from proteins annotated in the Gene Ontology database with the 
term “DNA repair” are highlighted in Fig. 2C. Only ubiquitinated 
peptides more abundant in the lysates from cells expressing 
GFP-DTX2 were considered for further evaluation/validation and 
only the DNA repair peptides from this set are colored in the vol-
cano plot.
For SPR assays, Biacore T200 BIAevaluation software (GE Health-
care) was used for the analyses of data by steady-state affinity for 
2RD variants. The number of replicates (n) for each Kd (presented 
as mean) ± SEM measurement is indicated in fig. S3 and table S1.
For single-turnover lysine discharge assays (Fig. 4, D and E), 
data are presented as an average ± SD based on five replicates for 
each measurement. Image Studio software (version 5.2.5; LI-COR 
Biosciences) was used to quantify the intensity of each band (I), 
and GraphPad Prism (version 8.1.0) was used to generate the plot. 
The % UbcH5B∼Ub remaining was calculated using the following 
equation
  %UbcH5B~Ub remaining = 100 *  I t=2 min / I t=0 min 
In Fig. 4G, the ubiquitinated SPT16 species under different conditions 
from two replicates were quantified using the LI-COR Image Studio 
Lite software, and values assigned for each band are relative to DTX2 
WT. For immunocytochemistry and immunoblotting data, repre-
sentative images and blots were shown in the figures and the exper-
iments were performed in triplicate unless otherwise mentioned.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/34/eabc0629/DC1
View/request a protocol for this paper from Bio-protocol.
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